During the past decade, Tennessee Oncology - Chattanooga; Tennessee Oncology - East Third Street conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 1 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Tennessee Oncology - Chattanooga; Tennessee Oncology - East Third Street" #1 collaborator was "Jazz Pharmaceuticals" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Tennessee Oncology - Chattanooga; Tennessee Oncology - East Third Street" are "Diffuse Large B-Cell Lymphoma" (1 trials), "HER2-Negative Metastatic Breast Cancer" (1 trials), "HER2-Positive Metastatic Breast Cancer" (1 trials), "Locally Advanced or Early Breast Cancer" (1 trials) and "Small-Cell Lung Cancer" (1 trials). Many other conditions were trialed in "Tennessee Oncology - Chattanooga; Tennessee Oncology - East Third Street" in a lesser frequency.

Most popular intervention types in "Tennessee Oncology - Chattanooga; Tennessee Oncology - East Third Street" are "Drug" (4 trials). Other intervention types were less common.

The name of intervention was led by "Cyclophosphamide" (3 trials), "Doxorubicin" (3 trials), "Atezolizumab" (2 trials), "Carboplatin" (2 trials) and "Atezolizumab (MPDL3280A), an engineered anti-PDL1 antibody" (1 trials). Other intervention names were less common.

The vast majority of trials in "Tennessee Oncology - Chattanooga; Tennessee Oncology - East Third Street" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Tennessee Oncology - Chattanooga; Tennessee Oncology - East Third Street". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Tennessee Oncology - Chattanooga; Tennessee Oncology - East Third Street, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Tennessee Oncology - Chattanooga; Tennessee Oncology - East Third Street, 1 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".